新天药业：用于治疗癌因性疲乏的欣力康胶囊已于10月获得药物临床试验批准通知书

Group 1 - The company is currently advancing its innovative drug development as planned [2] - The Xinlikang capsule, used for treating cancer-related fatigue, received approval for clinical trials from the drug regulatory authority in October 2025 [2]